Doxazosin 2mg tablets

Země: Velká Británie

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivní složka:

Doxazosin mesilate

Dostupné s:

Kent Pharma (UK) Ltd

ATC kód:

C02CA04

INN (Mezinárodní Name):

Doxazosin mesilate

Dávkování:

2mg

Léková forma:

Oral tablet

Podání:

Oral

Třída:

No Controlled Drug Status

Druh předpisu:

Valid as a prescribable product

Přehled produktů:

BNF: 02050400

Informace pro uživatele

680
Artwork No.
Customer
Description
Market
Language
Size
Min. Font Size
Page No.
Version No.
Date
Software
180719/2
Ennogen
Doxazosin Leaflet
UK
English
130 x 480 mm
9 pt
1 of 1
1
18-07-19
Coreldraw 12
Packaging Development
Quality Assurance (QA)
Quality Control (QC)
Production
e-mail : [e-mail]
Ph : [phone]
Colours Used
Black
Keyline
Doxazosin 1mg, 2mg, 4mg and 8mg Tablets
(doxazosin mesilate)
PACKAGE LEAFLET: INFORMATION FOR THE USER
!
If you have any further questions, ask your
doctor, pharmacist or nurse.
2.
What you need to know before you take
Doxazosin Tablets
It is used to treat:
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE DOXAZOSIN TABLETS
!
Symptoms caused by the enlargement of the
prostate gland in men.
4.
Possible side effects
If you are undergoing eye surgery because of
cataracts (cloudiness of the lens) please inform your
eye specialist before the operation that you are using
or have previously used Doxazosin Tablets. This is
because doxazosin may cause complications during
the surgery which can be managed if your specialist is
prepared in advance.
Before starting treatment with Doxazosin Tablets your
doctor may perform tests to rule out other conditions
such as prostate cancer that may cause the same
symptoms as benign prostatic hyperplasia
(enlargement of the prostate gland).
Persistent painful erections may occur very rarely. If
this happens you should contact a doctor
immediately.
6.
Contents of the pack and other information
!
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. See section
4.
!
Keep this leaflet. You may need to read it again.
!
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.
WHAT IS IN THIS LEAFLET
1.
What Doxazosin Tablets are and what they are
used for
5.
How to store Doxazosin Tablets
!
High blood pressure
In patients taking this medicine to treat high blood
pressure (hyp

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Doxazosin 2mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.425mg of doxazosin mesilate equivalent to 2mg
doxazosin.
For excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablets
White, oblong tablets, scored and embossed D2 on the same side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
_HYPERTENSION: _
Doxazosin is indicated for the treatment of hypertension and can be
used as
the sole agent to control blood pressure in the majority of patients.
In patients
inadequately controlled on single antihypertensive therapy, doxazosin
may be
used in combination with a thiazide diuretic, beta-adrenoreceptor
blocking
agent, calcium antagonist or an angiotensin converting enzyme
inhibitor.
_BENIGN PROSTATIC HYPERPLASIA: _
Doxazosin is indicated for the treatment of urinary outflow
obstruction and
symptoms associated with benign prostatic hyperplasia (BPH). Doxazosin
may
also be used in BPH patients who are either hypertensive or
normotensive.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Doxazosin may be administered in the morning or in the evening.
HYPERTENSION:_ _
Doxazosin is used in a once daily regimen: the initial dose is 1mg to
minimize
the potential for postural hypotension and/or syncope (see section 4.4
Special
Warnings and Precautions for Use). Dosage may be increased after one
or two
weeks of therapy to 2 mg and thereafter, if necessary, to 4 mg. The
majority of
patients who respond to doxazosin will do so at a dose of 4mg or
less.Dosage
can be further increased, if necessary to 8 mg or the maximum
recommended
dose of 16 mg.
BENIGN PROSTATIC HYPERPLASIA:
The recommended initial dose of doxazosin is 1mg given once daily to
minimise the potential for postural hypotension and/or syncope (see
section
4.4 Special Warnings and Precautions for Use). Depending on the
individual
patients urodynamics and BPH symptomatology dosage may be increased to
2
mg and thereafter to 4 mg and up to the maximum recommended dose of 8
mg